Elsevier

Clinical Breast Cancer

Volume 8, Issue 1, February 2008, Pages 88-91
Clinical Breast Cancer

Original Contribution
Adjuvant Chemotherapy for Breast Cancer: Effects on Cerebral White Matter Seen in Diffusion Tensor Imaging

https://doi.org/10.3816/CBC.2008.n.007Get rights and content

Abstract

Purpose

The purpose of this study was to examine the effect of adjuvant chemotherapy on normal-appearing white matter in women with breast cancer.

Patients and Methods

Ten patients with early-stage breast cancer who were treated with adjuvant chemotherapy and 9 age-, education-, and IQ-matched healthy controls were studied with magnetic resonance imaging. Diffusion tensor imaging was used to calculate fractional anisotropy (FA), a measure of white matter integrity. Measurements were made in the genu and splenium of the corpus callosum. Participants also completed measures of processing speed, depression, and anxiety.

Results

Relative to controls, patients had slower processing speed and lower FA in the genu. Processing speed was positively correlated with FA in the genu.

Conclusion

The results of this pilot study suggest that adjuvant chemotherapy affects normal-appearing white matter in the genu of the corpus callosum and that this is related to the cognitive deficits experienced by patients.

References (27)

  • A Pfefferbaum et al.

    Microstructural but not macrostructural disruption of white matter in women with chronic alcoholism

    Neuroimage

    (2002)
  • JL Eberling et al.

    Estrogen-and tamoxifen-associated effects on brain structure and function

    Neuroimage

    (2004)
  • A Jemal et al.

    Cancer Statistics, 2007

    CA Cancer J Clin

    (2007)
  • AU Buzdar et al.

    Recent advances in adjuvant therapy of breast cancer

    Semin Oncol

    (1999)
  • TA Ahles et al.

    Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma

    J Clin Oncol

    (2002)
  • FS Van Dam et al.

    Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high dose versus standard-dose chemotherapy

    J Natl Cancer Inst

    (1998)
  • JS Wefel et al.

    The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma

    Cancer

    (2004)
  • HG Mar Fan et al.

    Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1 and 2 year follow-up of a prospective controlled study

    J Clin Oncol

    (2005)
  • A Stewart et al.

    A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer

    Clin Neuropsychol

    (2006)
  • IF Tannock et al.

    Cognitive impairment associated with chemotherapy for cancer: report of a workshop

    J Clin Oncol

    (2004)
  • M Inagaki et al.

    Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy

    Cancer

    (2007)
  • E Yoshikawa et al.

    No adverse effects of adjuvant chemotherapy on hippocampal volume in Japanese breast cancer survivors

    Breast Cancer Res Treat

    (2005)
  • MS Brown et al.

    White matter disease induced by high-dose chemotherapy: longitudinal study with MRI imaging and proton spectroscopy

    Am J Neuroradiol

    (1998)

    • Cited by (0)

    Electronic forwarding or copying is a violation of US and International Copyright Laws.

    Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients, is granted by CIG Media Group, LP, ISSN #1526-8209, provided the appropriate fee is paid directly to Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923 USA 978-750-8400.

    View full text
    Copyright © 2008 Elsevier Inc. All rights reserved.